Walden Group Healthcare M&A Blog

Clinical Diagnostic M&A Developments

07/08/2015
Composition The U.S. clinical testing industry consists of two segments: (a) hospital inpatient and outpatient testing (40%) and (b) commercial clinical laboratories, physician-office laboratories and other locations, as well as hospital outreach testing (60%).Hospital-based and affiliated laboratories account for ~60% of the total industry;...
Read More
Factors that Shaped 2014 Healthcare Mergers & Acquisitions (M&A)

02/26/2015
Healthcare M&A in 2014 was characterized by seismic changes. More than 40 deals were announced or closed with a value over $1 billion – 8 were over $10 billion. Here are the key factors that shaped the environment for healthcare mergers and acquisitions and healthcare investment banking. Healthcare Reform’s Effects Continue to Ripple...
Read More
Q3 2014 Healthcare M&A Trends

11/23/2014
In Q3 2014. big deals continued to dominate the healthcare M&A headlines, with transformative divestitures and restructurings also reshaping the landscape. Large scale M&A activity is how large companies are adapting to the new healthcare environment. In the new environment, tight government and hospital budgets loom large and cost has...
Read More
Urology Trends 2014

08/12/2014
Key dynamics in the urology sector, helping to fuel healthcare M&A activity, include: Urological Devices Market Expansion Fueled by increases in sales of urinary catheters and urological endoscopes, the U.S. urological devices market is estimated to reach over $5.4b by 2016. Urinary continence products account for almost 40% of the market ...
Read More
2014 Spine Surgery Sector Trends

03/25/2014
As a backdrop to healthcare M&A actvitiy, leading dynamics in the spine surgery sector include: Minimally invasive Spine Surgeries (MISS) increasingly being used to implant lumbar fusion devices, interspinous fusion systems, spinal non-fusion devices and to perform more simple procedures, such as discectomies. Traditional surgery requires a...
Read More